Patent · US Expired

Cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl derivatives as therapeutic agents

US5688819A · kind A · utility

217Cited by
11References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 22, 1996
Grant dateNov 18, 1997
Priority date
Expiry dateFeb 22, 2016

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/08
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides cyclopentane heptanoic acid, 2-cycloalkyl or arylalkyl compounds, which may be substituted in the 1-position with amino, amido, ether or ester groups, e.g., a 1-OH cyclopentane heptanoic acid, 2-(cycloalkyl or arylalkyl) compound. The cyclopentane heptanoic acid, 2-(cycloalkyl or arylalkyl) compounds of the present invention are potent ocular hypotensives, and are particularly suitable for the management of glaucoma. Moreover, the cyclopentane heptanoic, 2-(cycloalkyl or arylalkyl) compounds of this invention are smooth muscle relaxants with broad application in systemic hypertensive and pulmonary diseases; smooth muscle relaxants with application in gastrointestinal disease, reproduction, fertility, incontinence, shock, etc.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.